Pharmacy Question for the Week of June 7, 2021

Pharmacy Compliance Question of the Week

Question:

Are blood derivatives such as albumin infused for therapeutic treatment of liver failure or diseases such as cirrhosis billed as a biological by the pharmacy?

Answer:

Yes, understand that blood derivatives such as albumin infused for therapeutic treatment of liver failure or diseases such as cirrhosis or nephrotic syndrome resulting in hypoalbuminemia are billed as a biological by the pharmacy, and the administration of that substance is reported as drug administration, not blood transfusion.

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.